Artificial Intelligence (AI) is a highly advanced set of digital tools designed to mimic human problem-solving. At its core, it is a branch of computer science that builds systems capable of performing tasks that usually require human intelligence—such as recognizing faces in a photo, translating languages, or predicting the quickest route home in traffic.

Unlike traditional software that follows a rigid, “if-this-then-that” recipe, AI uses machine learning to find patterns from vast amounts of data. It “learns” from experience; the more information it processes, the better it becomes at making accurate predictions or generating creative content. Essentially, AI acts as a sophisticated cognitive assistant that helps us process complexity at a speed no human brain can match.

AI in Cardiovascular Health:

The intersection of artificial intelligence and vascular health marks a pivotal shift in how we approach chronic diseases. For patients battling high blood pressure (Hypertension), recovering from heart attacks, or managing diabetes-related vascular complications, AI is no longer a futuristic concept—it is a practical, life-saving tool that bridges the gap between the doctor’s office and daily life.

The Utility of AI in Vascular Management

Vascular diseases are often “silent” or characterized by complex, interaction in many organ systems like heart, kidney and brain. AI excels here because it can process vast amounts of data—such as heart rate variability, blood pressure trends, glucose and creatinine levels, —to find patterns that a human eye might miss.

Hypertension: Standard “cuff” measurements provide only a snapshot. AI-driven cuffless monitoring and wearable sensors allow for continuous data collection, identifying hypertension while person is sleeping or “white coat” (higher readings when measured in the clinic). Machine learning algorithms can then predict when a patient is likely to experience a dangerous spike.

Heart Attack Recovery: For survivors of heart attacks, the primary goal is preventing a second event. AI tools analyse post-infarction ECGs and imaging to detect subtle changes in heart wall motion or ejection fraction (how well the heart pumps), alerting clinicians to early signs of heart failure.

Diabetes-Associated Vascular Issues: Diabetes accelerates arterial damage. AI-powered imaging, such as retinal screening, can now detect microvascular damage in the eyes with high accuracy, serving as a proxy for the health of vessels in the heart and kidneys.

The Doctor’s Role: From Data Collector to Data Strategist

In the traditional model, doctors spend significant time gathering and interpreting raw data. AI shifts the doctor’s role toward personalized strategy and high-level decision-making. Example: In managing hypertension, doctors often rely on “trial and error” to find the right medication dose. Now, Clinical Decision Support Systems (CDSS) use AI to analyse a patient’s genetic profile, kidney function, and historical response to drugs and gives the list of medicines which will be most appropriate. Like if, a cardiologist uses an AI dashboard that suggests a specific ACE inhibitor ( Telmisartan / Olmesartan) dosage for a diabetic patient, predicting a better outcome based on the patient’s unique vascular resistance profile compared to standard guidelines.

The doctor’s new mandate is to act as the “human filter”—validating AI suggestions, managing the emotional toll of chronic illness, and intervening when the algorithm flags a high-risk anomaly, thus using drugs in a very low risk situation.

The Patient’s Role: The Active “Co-Pilot”

For the patient, AI transforms them from a passive recipient of care into an active participant. The “patient’s role” now involves high-fidelity self-monitoring and engagement with digital health ecosystems. Example: AI Voice Agents and Smart Wearables, Patients are now responsible for maintaining the flow of data that feeds the AI.

An elderly patient who previously suffered a heart attack uses a smartwatch with AI-enabled ECG. One afternoon, the watch detects an irregular rhythm (atrial fibrillation) that the patient cannot feel. The AI prompts the patient to sit down and automatically sends a report to their physician. The patient’s role was not to diagnose themselves, but to consistently wear the device and respond to its “nudges.”

Furthermore, AI-driven lifestyle coaching apps help diabetic patients understand the immediate vascular impact of their diet. A patient might see a real-time prediction of how a high-sodium meal will affect their blood pressure over the next six hours, encouraging immediate behavioural changes.

The true utility of AI lies in its ability to create a “closed-loop” system. In the case of hypertension associated with diabetes, the complexity is immense: blood sugar affects blood pressure, and high blood pressure damages the kidneys, which further raises blood pressure thus allowing a synergy.

AI manages this “triangle of risk” by: predicting a vascular event before it happens. It empowers the patient to take corrective action (diet, rest, or medication) and informs the doctor with precise, longitudinal data rather than sporadic office readings. This results in a much better treatment with follow up thus improving the outcomes of the disease.

The 2026 landscape of heart care is also being shaped by homegrown hardware like the Sarvam Kaze smart glasses. Engineered to “listen, understand, respond, and capture,” these Indian-made wearables allow the treating cardiologist to document procedures and access real-time AI insights hands-free. By shifting intelligence from a peripheral monitor directly to the cardiologist’s field of view, the Kaze facilitates a more seamless integration of patient data and live visual capture. This “AI-first” approach, powered by localized edge-AI models, ensures that critical decision-making in the physician’s room is supported by a device that literally sees what the wearer sees, reducing cognitive load and enhancing accuracy of the management during procedures like angioplasty in patients with previous heart attacks.

There are some down sides to AI based management which need to be kept in mind. These are that AI is like a black box which provides solutions but does not invariably give an explanation of why it chose so. It depends on a large body of available data which may not be specific to our ethnicity, it lacks emotion or empathy. Finally, it makes the power of thinking of the treating physician lose its sharp intellect.

As AI continues to evolve, the management of vascular disease will become increasingly proactive rather than reactive. The doctor provides the wisdom and the clinical oversight, the patient provides the data and the lifestyle commitment, and the AI provides the “connective tissue” that ensures neither side is not working in the dark. However, it needs to be used judiciously and over reliance can lead to serious issues. Human mind needs to govern it and not vice versa.

Prof Upendra Kaul, Founder Director, Gauri Kaul foundation

© Greater Kashmir